Analysts Set Kenvue Inc. (NYSE:KVUE) Price Target at $22.64

Shares of Kenvue Inc. (NYSE:KVUE) have been given an average rating of “Hold” by the twelve research firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $22.64.

KVUE has been the subject of several analyst reports. Jefferies Financial Group initiated coverage on shares of Kenvue in a report on Tuesday, September 24th. They issued a “buy” rating and a $27.00 price target for the company. JPMorgan Chase & Co. raised their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Bank of America raised their price target on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. Royal Bank of Canada downgraded shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a report on Tuesday, September 24th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th.

Hedge Funds Weigh In On Kenvue

A number of large investors have recently added to or reduced their stakes in the business. Tidal Investments LLC increased its position in shares of Kenvue by 9.9% in the third quarter. Tidal Investments LLC now owns 131,128 shares of the company’s stock valued at $3,033,000 after acquiring an additional 11,849 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Kenvue in the third quarter valued at about $1,057,000. Sanctuary Advisors LLC increased its position in shares of Kenvue by 166.3% in the third quarter. Sanctuary Advisors LLC now owns 544,890 shares of the company’s stock valued at $13,121,000 after acquiring an additional 340,266 shares during the period. Boyar Asset Management Inc. increased its position in shares of Kenvue by 7.2% in the third quarter. Boyar Asset Management Inc. now owns 29,171 shares of the company’s stock valued at $675,000 after acquiring an additional 1,948 shares during the period. Finally, Bard Financial Services Inc. increased its position in shares of Kenvue by 5.7% in the third quarter. Bard Financial Services Inc. now owns 106,790 shares of the company’s stock valued at $2,470,000 after acquiring an additional 5,750 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Up 0.7 %

KVUE opened at $24.26 on Friday. The company has a 50 day moving average of $22.96 and a 200 day moving average of $21.02. The company has a market cap of $46.51 billion, a PE ratio of 44.11, a price-to-earnings-growth ratio of 2.19 and a beta of 1.36. Kenvue has a 12 month low of $17.67 and a 12 month high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same period last year, the firm earned $0.31 EPS. Kenvue’s revenue for the quarter was down .4% on a year-over-year basis. On average, sell-side analysts expect that Kenvue will post 1.07 EPS for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th were given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a yield of 3.38%. The ex-dividend date of this dividend was Wednesday, November 13th. Kenvue’s payout ratio is presently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.